Semaglutide delays 4‐hour gastric emptying in women with polycystic ovary syndrome and obesity

Quantification of gastric emptying with magnetic resonance imaging in healthy volunteers: A systematic review

(2022) Davide Bertoli et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Liraglutide 3 mg on weight, body composition, and hormonal and metabolic parameters in women with obesity and polycystic ovary syndrome: a randomized placebo-controlled-phase 3 study

(2022) Karen E. Elkind-Hirsch et al.   FERTILITY AND STERILITY

The potential role of incretin-based therapies for polycystic ovary syndrome: a narrative review of the current evidence

(2021) Mohammed Altigani Abdalla et al.   Therapeutic Advances in Endocrinology and Metabolism

New Horizons. A New Paradigm for Treating to Target with Second-Generation Obesity Medications

(2021) W Timothy Garvey   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Plasma GLP-1 Response to Oral and Intraduodenal Nutrients in Health and Type 2 Diabetes—Impact on Gastric Emptying

(2021) Cong Xie et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

GLP ‐1 receptor agonists and the appropriate measurement of gastric emptying

(2020) Michael Horowitz et al.   DIABETES OBESITY & METABOLISM

Acute Effects of Lixisenatide on Energy Intake in Healthy Subjects and Patients with Type 2 Diabetes: Relationship to Gastric Emptying and Intragastric Distribution

(2020) Ryan Jalleh et al.   Nutrients

GLP-1 receptor agonists in the treatment of type 2 diabetes – state-of-the-art

(2020) Michael A. Nauck et al.   Molecular Metabolism

The effect of semaglutide 2.4 mg once weekly on energy intake, appetite, control of eating, and gastric emptying in adults with obesity

(2020) Martin Friedrichsen et al.   DIABETES OBESITY & METABOLISM

Advances in the physiology of gastric emptying

(2019) Raj K. Goyal et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Magnitude of slowing gastric emptying by glucagon‐like peptide‐1 receptor agonists determines the amelioration of postprandial glucose excursion in Japanese patients with type 2 diabetes

(2019) Yumi Suganuma et al.   Journal of Diabetes Investigation

GLP-1 Analog Modulates Appetite, Taste Preference, Gut Hormones and Regional Body Fat Stores in Adults with Obesity

(2019) Hoda Kadouh et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Effects of sequential treatment with lixisenatide, insulin glargine, or their combination on meal‐related glycaemic excursions, insulin and glucagon secretion, and gastric emptying in patients with type 2 diabetes

(2019) Juris J. Meier et al.   DIABETES OBESITY & METABOLISM

Comparative effects of proximal and distal small intestinal administration of metformin on plasma glucose and glucagon-like peptide-1, and gastric emptying after oral glucose, in type 2 diabetes

(2018) Malcolm J. Borg et al.   DIABETES OBESITY & METABOLISM

Insulin resistance in polycystic ovary syndrome: a systematic review and meta-analysis of euglycaemic–hyperinsulinaemic clamp studies

(2016) Samantha Cassar et al.   HUMAN REPRODUCTION

Differing effects of liraglutide on gastric emptying in Japanese patients with type 2 diabetes

(2013) Y. Nagai et al.   DIABETES OBESITY & METABOLISM

Liraglutide suppresses postprandial triglyceride and apolipoprotein B48 elevations after a fat-rich meal in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, cross-over trial

(2013) K. Hermansen et al.   DIABETES OBESITY & METABOLISM

Effects of the once-daily GLP-1 analog liraglutide on gastric emptying, glycemic parameters, appetite and energy metabolism in obese, non-diabetic adults

(2013) J van Can et al.   INTERNATIONAL JOURNAL OF OBESITY

Effect of the once-daily human GLP-1 analogue liraglutide on appetite, energy intake, energy expenditure and gastric emptying in type 2 diabetes

(2012) Michael Horowitz et al.   DIABETES RESEARCH AND CLINICAL PRACTICE